Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance
Open Access
- 13 March 2025
- journal article
- review article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 24
Abstract
Breast cancer is one of the leading causes of cancer-related deaths in women worldwide. Circular RNAs (circRNAs), a novel class of endogenous noncoding RNA with a covalently closed continuous loop that lacks the 5′-cap structure and the 3′-poly A tail, are more stable than linear RNAs and less susceptible to degradation by nucleases. CircRNAs are widespread in multiple mammalian genomes and have been detected in various tissues, cells and body fluids. Increasing evidence shows that abnormal expression of circRNAs is involved in the development of a variety of diseases, including breast cancer. Numerous studies have explored the potential of circRNAs as biomarkers in various malignant tumors. In this review, we aim to provide a comprehensive overview of the latest advances in circRNAs as promising biomarkers in the early diagnosis, prognosis, molecular type, metastasis and drug resistance of breast cancer.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2021MH045)
- special funds for scientific research on breast diseases of Shandong Medical Association (YXH2021ZX058)
This publication has 107 references indexed in Scilit:
- CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple‐negative breast cancer by targeting miR‐761/DACT2 signaling axisMolecular Carcinogenesis, 2022
- A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2‐positive breast cancer through regulating ferroptosisEnvironmental Toxicology, 2022
- Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on triple-negative breast cancer cells in vitroInflammation Research, 2022
- Serum Circ‐FAF1/Circ‐ELP3: A novel potential biomarker for breast cancer diagnosisJournal of Clinical Laboratory Analysis, 2021
- Circ_0001667 knockdown blocks cancer progression and attenuates adriamycin resistance by depleting NCOA3 via releasing miR‐4458 in breast cancerDrug Development Research, 2021
- Hsa_circRNA_102229 facilitates the progression of triple‐negative breast cancer via regulating the miR‐152‐3p/PFTK1 pathwayThe Journal of Gene Medicine, 2021
- Circular RNA La‐related RNA‐binding protein 4 correlates with reduced tumor stage, as well as better prognosis, and promotes chemosensitivity to doxorubicin in breast cancerJournal of Clinical Laboratory Analysis, 2020
- Profiling and integrated analysis of differentially expressed circRNAs as novel biomarkers for breast cancerJournal of Cellular Physiology, 2020
- hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR‐7‐5p and activating the MAPK/ERK signaling pathwayMolecular Carcinogenesis, 2018
- Breast cancer diagnosis: Imaging techniques and biochemical markersJournal of Cellular Physiology, 2018